Molecular insights into hyperglycemia-associated coronary heart disease: From glycemic variability and heart rate dynamics to long noncoding RNAs - Baishideng Publishing Group
Molecular insights into hyperglycemia-associated coronary heart disease: From glycemic variability and heart rate dynamics to long noncoding RNAs - Baishideng Publishing Group
Molecular insights into hyperglycemia-associated coronary heart disease: From glycemic variability and heart rate dynamics to long noncoding RNAs Baishideng Publishing Group
Molecular insights into hyperglycemia-associated coronary heart disease: From glycemic variability and heart rate dynamics to long noncoding RNAs Baishideng Publishing Group
Related Articles
HealthWhy Drug Companies Are Rushing to Market Ketamine Medicines
Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of the anesthetic.
HealthNew Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.
HealthV.A. Institutes New Consent Requirements for Some Psychiatric Drugs
Veterans under 30 will have to sign forms before being given antidepressants. Medical groups fear the moves may stigmatize mental health treatment.
HealthBattle of Hospital A.I. vs. Insurer A.I. Is Pushing Medical Costs Higher
The use of artificial intelligence by hospitals and health insurers is escalating their longstanding feud over paying for medical care.